Augustine Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Augustine Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-51,067	Closed	-$2.96M	–	99
2023 Q3	$2.96M	Sell	51,067 -810	-2%	-$49.6K	1.37%	21
2023 Q2	$3.32M	Sell	51,877 -106	-0.2%	-$7.11K	1.53%	16
2023 Q1	$3.6M	Sell	51,983 -275	-0.5%	-$19.4K	1.78%	16
2022 Q4	$3.76M	Sell	52,258 -682	-1%	-$51.4K	2.08%	14
2022 Q3	$3.76M	Buy	52,940 +10	+0%	+$725	2.47%	11
2022 Q2	$4.08M	Sell	52,930 -3,769	-7%	-$287K	2.5%	12
2022 Q1	$4.14M	Buy	56,699 +3	+0%	+$201	2.08%	16
2021 Q4	$3.54M	Sell	56,696 -1,903	-3%	-$112K	1.73%	20
2021 Q3	$3.47M	Buy	58,599 +7,134	+14%	+$470K	1.85%	17
2021 Q2	$3.44M	Sell	51,465 -1,173	-2%	-$76.5K	1.77%	19
2021 Q1	$3.32M	Sell	52,638 -292	-0.6%	-$18.2K	1.75%	19
2020 Q4	$3.28M	Sell	52,930 -1,064	-2%	-$65.4K	1.7%	18
2020 Q3	$3.25M	Sell	53,994 -1,730	-3%	-$104K	1.91%	17
2020 Q2	$3.28M	Sell	55,724 -733	-1%	-$43.8K	1.98%	17
2020 Q1	$3.15M	Buy	56,457 +6,546	+13%	+$400K	2.23%	14
2019 Q4	$3.2M	Buy	49,911 +38,654	+343%	+$2.21M	1.94%	20
2019 Q3	$571K	Sell	11,257 -433	-4%	-$20.4K	0.38%	45
2019 Q2	$530K	Buy	11,690 +1,907	+19%	+$88.8K	0.37%	47
2019 Q1	$466K	Buy	+9,783	New	+$487K	0.31%	54
2015 Q1	–	Sell	-5,180	Closed	-$305K	–	60
2014 Q4	$305K	Hold	5,180	–	–	0.2%	51
2014 Q3	$265K	Hold	5,180	–	–	0.17%	52
2014 Q2	$251K	Hold	5,180	–	–	0.16%	55
2014 Q1	$269K	Hold	5,180	–	–	0.19%	51
2013 Q4	$275K	Hold	5,180	–	–	0.16%	61
2013 Q3	$240K	Hold	5,180	–	–	0.17%	49
2013 Q2	$231K	Buy	+5,180	New	+$225K	0.16%	52

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Augustine Asset Management's BMY Position: Q4 2023 in Review

Augustine Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 51,067 shares — an estimated $2.96M sold.

Augustine Asset Management first reported a position in BMY in Q2 2013 and held it in 26 quarters. The position peaked at $4.14M in Q1 2022. 2,364 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Augustine Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Augustine Asset Management sold 51,067 Bristol-Myers Squibb shares in Q4 2023, an estimated $2.96M.
Augustine Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 26 quarters.
Augustine Asset Management's Bristol-Myers Squibb position peaked at $4.14M in Q1 2022.
2,364 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Augustine Asset Management's 13F filing for Q4 2023, filed 24 Jan 2024.